US3097139A
(en)
*
|
1960-03-10 |
1963-07-09 |
Ici Ltd |
Hypocholesterolaemia compositions
|
BE630211A
(ko)
*
|
1962-03-28 |
|
|
|
GB992152A
(en)
*
|
1962-07-11 |
1965-05-19 |
Prodotti Schering Soc It |
Aminoesters
|
US3332842A
(en)
*
|
1963-08-30 |
1967-07-25 |
Ciba Geigy Corp |
Ether acids and derivatives thereof
|
US3332957A
(en)
*
|
1964-09-02 |
1967-07-25 |
Ciba Geigy Corp |
Amino esters of substituted phenoxy acetic acids
|
SE337383B
(ko)
*
|
1965-01-05 |
1971-08-09 |
Yoshitomi Pharmaceutical |
|
US3452081A
(en)
*
|
1965-05-27 |
1969-06-24 |
Merck & Co Inc |
Phenoxy substituted 2-alkenoic acids
|
US3538227A
(en)
*
|
1967-01-30 |
1970-11-03 |
Ciba Geigy Corp |
Tricyclic phenoxy-acid and ester hypocholesterolemic compositions
|
SE344742B
(ko)
*
|
1968-09-25 |
1972-05-02 |
Ciba Geigy Ag |
|
US4031134A
(en)
*
|
1969-04-16 |
1977-06-21 |
Sumitomo Chemical Company, Limited |
Phenoxy carboxylic acid derivative
|
FI52570C
(fi)
*
|
1969-04-16 |
1977-10-10 |
Sumitomo Chemical Co |
Menetelmä veren kolesteroli- tai lipoidipitoisuutta alentavien fenoxia lifaattisten karboksyylihappoyhdisteiden ja -esteriyhdisteiden valmist amiseksi.
|
US3692895A
(en)
*
|
1970-09-08 |
1972-09-19 |
Norman A Nelson |
Method of reducing hypercholesteremia in humans employing a copolymer of polyethylenepolyamine and a bifunctional substance, such as epichlorohydria
|
GB1348642A
(en)
*
|
1970-10-15 |
1974-03-20 |
Howard A N |
Hypocholesterolaemic compositions
|
JPS575214B2
(ko)
*
|
1972-06-01 |
1982-01-29 |
|
|
US3952096A
(en)
*
|
1973-06-15 |
1976-04-20 |
Bristol-Myers Company |
Mixture of calcium carbonate and calcium-α-p-chlorophenoxyisobutyrate as an antihyperlipemic agent
|
DE2342118C2
(de)
*
|
1973-08-21 |
1982-09-23 |
Merck Patent Gmbh, 6100 Darmstadt |
Phenoxypropionsäurederivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen
|
US4039683A
(en)
*
|
1973-08-21 |
1977-08-02 |
Merck Patent Gesellschaft Mit Beschrankter Haftung |
Phenoxypropionic acid derivatives and pharmaceutical preparations containing same
|
CH617417A5
(ko)
*
|
1973-12-27 |
1980-05-30 |
Siegfried Ag |
|
NL7416412A
(nl)
*
|
1973-12-27 |
1975-07-01 |
Siegfried Ag |
Werkwijze ter bereiding van nieuwe cholesterol- gende verbindingen.
|
AT353776B
(de)
*
|
1973-12-27 |
1979-12-10 |
Siegfried Ag |
Verfahren zur herstellung von neuen alkan- saeuren, deren estern und salzen
|
US4182902A
(en)
*
|
1973-12-27 |
1980-01-08 |
Siegfried Aktiengesellschaft |
Novel cholesterol-lowering compounds
|
US4012523A
(en)
*
|
1974-01-24 |
1977-03-15 |
The Dow Chemical Company |
Hypolipidemic 2-(3,5-di-tert-butyl-4-hydroxyphenyl)-(thio or sulfonyl) alkanoic acids and derivatives
|
US4067998A
(en)
*
|
1974-02-11 |
1978-01-10 |
The Dow Chemical Company |
2-((3,5-Di-tert-butylphenyl)thio) alkanoic acids and derivatives
|
DK115374A
(ko)
|
1974-03-04 |
1975-11-03 |
Byk Gulden Lomberg Chem Fab |
|
US4243819A
(en)
*
|
1978-02-16 |
1981-01-06 |
Zoecon Corporation |
Substituted amino acids
|
US4250191A
(en)
*
|
1978-11-30 |
1981-02-10 |
Edwards K David |
Preventing renal failure
|
JPS58150563A
(ja)
*
|
1982-03-04 |
1983-09-07 |
Taisho Pharmaceut Co Ltd |
3−ベンゾイル−2−メルカプトプロピオン酸誘導体
|
US4704402A
(en)
*
|
1982-06-12 |
1987-11-03 |
University Of Pittsburgh |
Method of treating sickle cell anemia
|
US4482571A
(en)
*
|
1982-06-21 |
1984-11-13 |
University Of Pittsburgh |
Sickle cell anemia treatment and compound
|
IN160141B
(ko)
*
|
1983-05-09 |
1987-06-27 |
Council Scient Ind Res |
|
EP0320501A3
(en)
*
|
1983-06-24 |
1989-12-06 |
Yamanouchi Pharmaceutical Co., Ltd. |
Phenoxy derivatives, their preparation, and pharmaceutical compositions containing them
|
DK305884A
(da)
*
|
1983-06-24 |
1984-12-25 |
Yamanouchi Pharma Co Ltd |
Phenoxyderivat, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat indeholdende et saadant derivat
|
DE3621861A1
(de)
*
|
1986-06-30 |
1988-01-14 |
Laszlo Dr Med Ilg |
Verwendung von aryloxycarbonsaeure-derivaten gegen dermatologische erkrankungen
|
US4859703A
(en)
*
|
1987-06-15 |
1989-08-22 |
Warner-Lambert Company |
Lipid regulating compositions
|
CA2076012A1
(en)
*
|
1990-02-14 |
1991-08-15 |
Yasuyuki Kato |
Agent for inhibiting the formation of denatured ldl
|
US6642268B2
(en)
|
1994-09-13 |
2003-11-04 |
G.D. Searle & Co. |
Combination therapy employing ileal bile acid transport inhibiting benzothipines and HMG Co-A reductase inhibitors
|
US6268392B1
(en)
|
1994-09-13 |
2001-07-31 |
G. D. Searle & Co. |
Combination therapy employing ileal bile acid transport inhibiting benzothiepines and HMG Co-A reductase inhibitors
|
US6262277B1
(en)
|
1994-09-13 |
2001-07-17 |
G.D. Searle And Company |
Intermediates and processes for the preparation of benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
|
US6083497A
(en)
|
1997-11-05 |
2000-07-04 |
Geltex Pharmaceuticals, Inc. |
Method for treating hypercholesterolemia with unsubstituted polydiallylamine polymers
|
US6348497B1
(en)
|
1998-06-02 |
2002-02-19 |
Arthromics Plc |
Compounds which interact with the thyroid hormone receptor for the treatment of fibrotic disease
|
CA2356157C
(en)
|
1998-12-23 |
2008-04-01 |
G.D. Searle Llc |
Combinations of cholesteryl ester transfer protein inhibitors and fibric acid derivatives for cardiovascular indications
|
EP1140185B1
(en)
|
1998-12-23 |
2003-06-04 |
G.D. Searle LLC. |
Combinations of cholesteryl ester transfer protein inhibitors and bile acid sequestering agents for cardiovascular indications
|
DK1140188T3
(da)
|
1998-12-23 |
2003-09-29 |
Searle Llc |
Kombinationer af ileale galdesyretransporthæmmere og cholesterylestere tranferproteinhæmmere til cardiovaskulære indikationer
|
HUP0104793A2
(en)
|
1998-12-23 |
2002-06-29 |
Searle Llc |
Combinations of ileal bile acid transport inhibitors and fibric acid derivatives for cardiovascular indications
|
CZ20012345A3
(cs)
*
|
1998-12-23 |
2001-12-12 |
G. D. Searle Llc Corporate Patent Department |
Kombinace inhibitorů transportu kyčelní ľlučové kyseliny a činidel pro sekvenci ľlučové kyseliny pro kardiovaskulární indikace
|
US6462091B1
(en)
|
1998-12-23 |
2002-10-08 |
G.D. Searle & Co. |
Combinations of cholesteryl ester transfer protein inhibitors and HMG coA reductase inhibitors for cardiovascular indications
|
AU779264B2
(en)
*
|
1998-12-23 |
2005-01-13 |
G.D. Searle Llc |
Combinations for cardiovascular indications
|
DK1140184T3
(da)
|
1998-12-23 |
2003-09-29 |
Searle Llc |
Kombinationer af cholesterylestertransferproteinhæmmere og nikotinsyrederivater til hjertekar indikationer
|
US6794544B2
(en)
|
2000-03-10 |
2004-09-21 |
Pharmacia Corporation |
Method for the preparation of tetrahydrobenzothiepines
|
AU2001247331A1
(en)
*
|
2000-03-10 |
2001-09-24 |
Pharmacia Corporation |
Combination therapy for the prophylaxis and treatment of hyperlipidemic conditions and disorders
|
US20040077625A1
(en)
*
|
2001-07-25 |
2004-04-22 |
Tremont Samuel J. |
Novel 1,4-benzothiazepine and 1,5-benzothiazepine compounds as inhibitors of apical sodium codependent bile acid transport abd taurocholate uptake
|
CA2464685A1
(en)
*
|
2001-11-02 |
2003-05-15 |
G.D. Searle Llc |
Novel mono- and di-fluorinated benzothiepine compounds as inhibitors of apical sodium co-dependent bile acid transport (asbt) and taurocholate uptake
|
AU2003207431A1
(en)
|
2002-01-17 |
2003-09-02 |
Pharmacia Corporation |
Novel alkyl/aryl hydroxy or keto thiepines.
|
ITRM20020629A1
(it)
*
|
2002-12-19 |
2004-06-20 |
Sigma Tau Ind Farmaceuti |
Uso di acidi alfa-feniltiocarbossilici e alfa-fenilossicarbossilici ad attivita' ipoglicemizzante e/o ipolipidemizzante.
|
WO2004108126A1
(en)
*
|
2003-06-06 |
2004-12-16 |
Snowden Pharmaceuticals, Llc |
Fibric acid derivatives for the treatment of irritable bowel syndrome
|
WO2005046662A2
(en)
*
|
2003-11-07 |
2005-05-26 |
Jj Pharma, Inc. |
Hdl-boosting combination therapy complexes
|
US20070190079A1
(en)
*
|
2004-10-29 |
2007-08-16 |
Kalypsys, Inc. |
Methods for the selective modulation of ppar
|
FR2880887B1
(fr)
*
|
2005-01-14 |
2009-01-30 |
Merck Sante Soc Par Actions Si |
Derives d'hydroxyphenols, procedes pour leur preparation, compositions pharmaceutiques les contenant et applications en therapeutique
|
TW200831497A
(en)
*
|
2006-10-12 |
2008-08-01 |
Epix Delaware Inc |
Carboxamide compounds and their use
|
AR065670A1
(es)
|
2007-03-09 |
2009-06-24 |
Indigene Pharmaceuticals Inc |
Combinacion de metformina r-(+) lipoato y agentes antihiperlipidemicos para el tratamiento de hiperglucemia diabetica y complicaciones diabeticas
|
US20090054450A1
(en)
*
|
2007-06-19 |
2009-02-26 |
Ironwood Pharmaceuticals, Inc. |
Compositions and methods of use for treating or preventing lipid related disorders
|
WO2009076404A1
(en)
*
|
2007-12-10 |
2009-06-18 |
Epix Delaware, Inc. |
Carboxamide compounds and their use as antagonists of the chemokine ccr2 receptor
|
JP2011506466A
(ja)
|
2007-12-11 |
2011-03-03 |
株式会社サイトパスファインダー |
カルボキサミド化合物ならびにケモカイン受容体アゴニストとしてのそれらの使用
|
MX2012001520A
(es)
|
2009-08-03 |
2012-06-01 |
Acraf |
Proceso para la preparacion de 1-bencil-3-hidroximetil-1h-indazol y sus derivados e intermediarios de magnesio requeridos.
|
DK3253382T3
(da)
|
2015-02-06 |
2022-02-14 |
Intercept Pharmaceuticals Inc |
Farmaceutiske sammensætninger til kombinationsterapi
|
KR101956805B1
(ko)
*
|
2019-02-21 |
2019-03-11 |
한국식품연구원 |
부테인 또는 이소유제놀을 포함하는 pcsk9 유전자의 발현 감소 또는 저밀도 지단백 수용체 증가용 조성물
|